Institute for Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Institute for Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,068	Closed	-$234K	–	521
2024 Q3	$234K	Buy	+6,068	New	+$216K	0.03%	481
2024 Q2	–	Sell	-6,068	Closed	-$236K	–	506
2024 Q1	$236K	Buy	+6,068	New	+$212K	0.03%	445
2023 Q4	–	Sell	-12,606	Closed	-$282K	–	486
2023 Q3	$282K	Hold	12,606	–	–	0.05%	361
2023 Q2	$271K	Hold	12,606	–	–	0.05%	381
2023 Q1	$302K	Sell	12,606 -9,711	-44%	-$258K	0.06%	349
2022 Q4	$518K	Hold	22,317	–	–	0.11%	254
2022 Q3	$358K	Hold	22,317	–	–	0.08%	304
2022 Q2	$395K	Buy	22,317 +9,711	+77%	+$163K	0.08%	331
2022 Q1	$257K	Hold	12,606	–	–	0.04%	460
2021 Q4	$235K	Sell	12,606 -3,583	-22%	-$69.8K	0.04%	434
2021 Q3	$320K	Hold	16,189	–	–	0.06%	359
2021 Q2	$383K	Hold	16,189	–	–	0.07%	322
2021 Q1	$384K	Buy	+16,189	New	+$385K	0.07%	312

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Institute for Wealth Management's COLL Position: Q4 2024 in Review

Institute for Wealth Management sold out of Collegium Pharmaceutical (COLL) in Q4 2024, closing a stake of 6,068 shares — an estimated $234K sold.

Institute for Wealth Management first reported a position in COLL in Q1 2021 and held it in 13 quarters. The position peaked at $518K in Q4 2022. 238 funds tracked by Wall St. Rank hold COLL as of Q4 2024.

Institute for Wealth Management reported no remaining Collegium Pharmaceutical position as of Q4 2024 after selling out during the quarter.
Institute for Wealth Management sold 6,068 Collegium Pharmaceutical shares in Q4 2024, an estimated $234K.
Institute for Wealth Management first reported a position in Collegium Pharmaceutical in Q1 2021 and held it in 13 quarters.
Institute for Wealth Management's Collegium Pharmaceutical position peaked at $518K in Q4 2022.
238 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2024.

Based on Institute for Wealth Management's 13F filing for Q4 2024, filed 23 Jan 2025.